Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

about

Towards lipidomics of low-abundant species for exploring tumor heterogeneity guided by high-resolution mass spectrometry imaging

P2860

Q28393497-2EFFC3D7-CAFB-4ADB-83F4-7D4A2A6AAE12

P2860

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

Item

http://www.wikidata.org/entity/Q39335230

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

@en

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

@nl

type

Item

label

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

@en

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

@nl

prefLabel

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

@en

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

@nl

P1476

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

@en

P2093

Brian S Cummings

http://www.w3.org/2001/XMLSchema#string

Jason N Mock

http://www.w3.org/2001/XMLSchema#string

John P Taliaferro

http://www.w3.org/2001/XMLSchema#string

Sravan Kumar Patel

http://www.w3.org/2001/XMLSchema#string

Timothy E Long

http://www.w3.org/2001/XMLSchema#string

Xiao Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Human Pancreatic Islets Express mRNA Species Encoding Two Distinct Catalytically Active Isoforms of Group VI Phospholipase A2 (iPLA2) [etc.]

Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance.

Cloning and expression of a group IV cytosolic Ca2+-dependent phospholipase A2 from rat pancreatic islets. Comparison of the expressed activity with that of an islet group VI cytosolic Ca2+-independent phospholipase A2.

Pancreatic islets and insulinoma cells express a novel isoform of group VIA phospholipase A2 (iPLA2 beta) that participates in glucose-stimulated insulin secretion and is not produced by alternate splicing of the iPLA2 beta transcript

Phospholipase A(2)s in cell injury and death.

Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase.

Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance.

Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders.

The phospholipase A2 superfamily and its group numbering system.

Catalytic features, regulation and function of myocardial phospholipase A2.

P304

4854-4858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMCL.2012.05.038

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225282374

http://www.w3.org/2001/XMLSchema#string

P698

22677312

http://www.w3.org/2001/XMLSchema#string

P932

3376906

http://www.w3.org/2001/XMLSchema#string

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

about

P2860

P2860

Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932